AFS
NVCR icon

Annapolis Financial Services’s NovoCure NVCR Stock Holding History

Annapolis Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15
Closed -$1K – 502
2022
Q3 		$1K Hold
15
– – ﹤0.01% 484
2022
Q2 		$1K Hold
15
– – ﹤0.01% 417
2022
Q1 		$1K Hold
15
– – ﹤0.01% 437
2021
Q4 		$1K Buy
15
+2
+15% +$201 ﹤0.01% 443
2021
Q3 		$2K Hold
13
– – ﹤0.01% 403
2021
Q2 		$3K Hold
13
– – ﹤0.01% 361
2021
Q1 		$2K Hold
13
– – ﹤0.01% 367
2020
Q4 		$2K Buy
+13
New +$1.78K ﹤0.01% 366

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Annapolis Financial Services's NVCR Position: Q4 2022 in Review

Annapolis Financial Services sold out of NovoCure (NVCR) in Q4 2022, closing a stake of 15 shares — an estimated $1K sold.

Annapolis Financial Services first reported a position in NVCR in Q4 2020 and held it in 8 quarters. The position peaked at $3K in Q2 2021. 304 funds tracked by Wall St. Rank hold NVCR as of Q4 2022.

  • Annapolis Financial Services reported no remaining NovoCure position as of Q4 2022 after selling out during the quarter.
  • Annapolis Financial Services sold 15 NovoCure shares in Q4 2022, an estimated $1K.
  • Annapolis Financial Services first reported a position in NovoCure in Q4 2020 and held it in 8 quarters.
  • Annapolis Financial Services's NovoCure position peaked at $3K in Q2 2021.
  • 304 funds tracked by Wall St. Rank held NovoCure as of Q4 2022.

Based on Annapolis Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.